Literature DB >> 19496040

[Treatment of insomnia].

Ulrich Michael Hemmeter1, Andreas Thum.   

Abstract

The prevalence of insomnia is high in the population of western industrial countries (up to 35 %). Sleep disturbance may consequently lead to an impairment of cognitive functions, mood disturbance and metabolic alterations. Therefore, the confirmation of insomnia and its diagnostic characterization is of great importance. Treatment of insomnia is based on its aetiology and intensity. For secondary insomnia treatment of the basic disorder is mandatory. Before the initiation of a symptomatic pharmacological treatment the application of non-pharmacological interventions should be considered. Efficacious pharmacological interventions are non-benzodiazepine hypnotics for a limited time span. If a longer treatment of insomnia is necessary, hypnotic antidepressants and hypnotic neuroleptics (without anti-cholinergic action) can be applied taking the specific side effects into account. Classical benzodiazepines and substances with anti-cholinergic properties should be avoided in particular in long-term treatment and in elderly subjects due to its side effect profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19496040     DOI: 10.1024/0040-5930.66.6.441

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  1 in total

1.  A Preliminary Study of the Effects of SurAsleep on Relieving Symptoms of Sleep Disorders.

Authors:  Qingwen Xie; Tian Zhou; Lawrence Yen; Andrew Song; Mina Shariff; Tuong Nguyen; Jianyu Rao; Rong Shi
Journal:  Int J Biomed Sci       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.